SCHEMBL19159167

SCHEMBL19159167

C=C(C)c1nn(Cc2ccc(OC)cc2)cc1C(Nc1cc(Cl)c(=O)n(C)c1)c1ccc(Cl)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.37
▸ ABCB1 P08183 1/20 0.35
▸ NPBWR1 P48145 2/20 0.35
▸ CNR2 P34972 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MAT2A P31153 1/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ FPR2 P25090 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ UTS2R Q9UKP6 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ THRB P10828 1/20 0.32
▸ P2RX3 P56373 1/20 0.32
▸ EGFR P00533 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16244484 0.91 TDP1 (0.39) TDP1ABCB1NPBWR1CNR2L3MBTL1
SCHEMBL19159691 0.91 NPBWR1 (0.35) TDP1ABCB1NPBWR1CNR2L3MBTL1
SCHEMBL16244426 0.88 NPBWR1 (0.42) TDP1ABCB1NPBWR1CNR2L3MBTL1
SCHEMBL16244388 0.84 ABCB1 (0.37) TDP1ABCB1CNR2L3MBTL1KMT2A
SCHEMBL16244627 0.82 NPBWR1 (0.42) ABCB1NPBWR1CNR2L3MBTL1KMT2A
SCHEMBL16244935 0.77 KMT2A (0.41) TDP1NPBWR1CNR2KMT2ASMN1; SMN2
SCHEMBL16244695 0.75 PDE4A (0.40) NPBWR1KMT2ASMN1; SMN2MEN1BRD4
SCHEMBL19158727 0.74 BRD4 (0.34) ABCB1SMN1; SMN2BRD4
SCHEMBL16244871 0.73 ABCB1 (0.37) ABCB1KMT2ASMN1; SMN2MEN1BRD4
SCHEMBL16259906 0.72 KDM4E (0.39) TDP1NPBWR1L3MBTL1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3004110-B1 PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2017-07-26 — — EP disclosed
Send feedback